DNAnexus Stock
HealthTechLooking to sell DNAnexus stock or options?
DNAnexus, a developer of a biomedical informatics and data management platform, is designed to process DNA-sequencing data analysis. The platform supports researchers in various sectors including biopharmaceutical, bioagricultural, sequencing services, clinical diagnostics, government, and research consortia to expedite their global genomics programs. This allows both commercial and academic medical researchers to visualize and analyze big data systems for DNA from a single, integrated system.
SV Angel, Genuity Science, First Round Capital, TPG, K9 Ventures, MidCap Financial, Northpond Ventures, WuXi Healthcare Ventures, Blackstone, Foresite Capital, Ares Management, Regeneron Pharmaceuticals, Innovatus Capital Partners, GV, Hercules Capital, Saints Capital, Uncork Capital, Claremont Creek Ventures, Felicis, Ares Capital, Aydin Senkut, Perceptive Advisors, Ally Bridge Group, Microsoft.